These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 9554433)
1. Ribozymes as therapeutic agents: are we getting closer? Scanlon KJ; Kashani-Sabet M J Natl Cancer Inst; 1998 Apr; 90(8):558-9. PubMed ID: 9554433 [No Abstract] [Full Text] [Related]
2. Application of preformed hammerhead ribozymes in the gene therapy of cancer (review). Sioud M Int J Mol Med; 1999 Apr; 3(4):381-4. PubMed ID: 10085409 [TBL] [Abstract][Full Text] [Related]
3. Ribozymes: use as anti-HIV therapeutic molecules. Dropulic B; Elkins DA; Rossi JJ; Sarver N Antisense Res Dev; 1993; 3(1):87-94. PubMed ID: 8495108 [No Abstract] [Full Text] [Related]
4. Catalytic antisense RNA (ribozymes): their potential and use as anti-HIV-1 therapeutic agents. Rossi JJ; Sarver N Adv Exp Med Biol; 1992; 312():95-109. PubMed ID: 1514448 [No Abstract] [Full Text] [Related]
5. HIV and Ribozymes. Scarborough RJ; Gatignol A Adv Exp Med Biol; 2015; 848():97-116. PubMed ID: 25757617 [TBL] [Abstract][Full Text] [Related]
6. Gene therapeutic agents: the use of ribozymes, antisense, and RNA decoys for HIV-1 infection. Smythe JA; Symonds G Inflamm Res; 1995 Jan; 44(1):11-5. PubMed ID: 7664023 [No Abstract] [Full Text] [Related]
7. RNA-mediated inhibition of HIV in a gene therapy setting. Michienzi A; Castanotto D; Lee N; Li S; Zaia JA; Rossi JJ Ann N Y Acad Sci; 2003 Dec; 1002():63-71. PubMed ID: 14751823 [TBL] [Abstract][Full Text] [Related]
9. Current status of ribozymes as gene therapy agents for cancer. Wright L; Kearney P Cancer Invest; 2001; 19(5):495-509. PubMed ID: 11458817 [No Abstract] [Full Text] [Related]
10. Therapeutic antisense and ribozymes. Rossi JJ Br Med Bull; 1995 Jan; 51(1):217-25. PubMed ID: 7767645 [TBL] [Abstract][Full Text] [Related]
14. The application of ribozymes to HIV infection. Rossi JJ Curr Opin Mol Ther; 1999 Jun; 1(3):316-22. PubMed ID: 11713796 [TBL] [Abstract][Full Text] [Related]
15. Alternative approaches for the application of ribozymes as gene therapies for retroviral infections. Campbell TB; Sullenger BA Adv Pharmacol; 1995; 33():143-78. PubMed ID: 7495669 [No Abstract] [Full Text] [Related]
16. Inhibition of human immunodeficiency virus type 1 replication by nuclear chimeric anti-HIV ribozymes in a human T lymphoblastoid cell line. Michienzi A; Conti L; Varano B; Prislei S; Gessani S; Bozzoni I Hum Gene Ther; 1998 Mar; 9(5):621-8. PubMed ID: 9551610 [TBL] [Abstract][Full Text] [Related]
17. Ribozymes as anti-HIV-1 therapeutic agents: principles, applications, and problems. Rossi JJ; Elkins D; Zaia JA; Sullivan S AIDS Res Hum Retroviruses; 1992 Feb; 8(2):183-9. PubMed ID: 1540406 [TBL] [Abstract][Full Text] [Related]
18. The use of ribozymes in gene therapy approaches to AIDS. James W Recent Results Cancer Res; 1998; 144():139-46. PubMed ID: 9304715 [No Abstract] [Full Text] [Related]
20. Can gene delivery close the door to HIV-1 entry after escape? Swan CH; Torbett BE J Med Primatol; 2006 Aug; 35(4-5):236-47. PubMed ID: 16872287 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]